Q5131 Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

Short descriptor: Inj, idacio, 20 mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q5131 was terminated as of 2024-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q5131 in the app →

Look up Q5131 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5131 is the HCPCS Level II code for Injection, adalimumab-aacf (idacio), biosimilar, 20 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2025-01-01
Termination Date
2024-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5131 with the canonical source and edition:

Q5131 — Injection, adalimumab-aacf (idacio), biosimilar, 20 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5131

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5131

Related Codes in Section Q

← Q5130 Inj, fylnetra, 0.5 mg Q5132 → Inj, abrilada, 10 mg
Q5127 Inj, stimufend, 0.5 mg Q5128 Inj, cimerli, 0.1 mg Q5129 Inj, vegzelma, 10 mg Q5130 Inj, fylnetra, 0.5 mg Q5132 Inj, abrilada, 10 mg Q5133 Inj, tofidence, 1 mg Q5134 Inj, tyruko, 1 mg Q5135 Inj, tyenne, 1 mg Q5136 Inj. denosumab-bbdz, 1 mg Q5137 Inj, wezlana, sub cu, 1 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial